These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23084660)

  • 1. Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients.
    Thaler J; Preusser M; Ay C; Kaider A; Marosi C; Zielinski C; Pabinger I; Hainfellner JA
    Thromb Res; 2013 Feb; 131(2):162-5. PubMed ID: 23084660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ahlbrecht J; Dickmann B; Ay C; Dunkler D; Thaler J; Schmidinger M; Quehenberger P; Haitel A; Zielinski C; Pabinger I
    J Clin Oncol; 2012 Nov; 30(31):3870-5. PubMed ID: 23008313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
    Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
    Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.
    Hernández C; Orbe J; Roncal C; Alvarez-Hernandez M; Martinez de Lizarrondo S; Alves MT; García Mata J; Páramo JA
    Thromb Haemost; 2013 Sep; 110(3):598-608. PubMed ID: 23803792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour expresion of tissue factor and tissue factor pathway inhibitor in ovarian cancer- relationship with venous thrombosis risk.
    Abu Saadeh F; Norris L; O'Toole S; Mohamed BM; Langhe R; O'Leary J; Gleeson N
    Thromb Res; 2013 Nov; 132(5):627-34. PubMed ID: 24094893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
    Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
    Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombosis in brain tumors.
    Jo JT; Schiff D; Perry JR
    Semin Thromb Hemost; 2014 Apr; 40(3):325-31. PubMed ID: 24599439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients.
    Thaler J; Ay C; Mackman N; Bertina RM; Kaider A; Marosi C; Key NS; Barcel DA; Scheithauer W; Kornek G; Zielinski C; Pabinger I
    J Thromb Haemost; 2012 Jul; 10(7):1363-70. PubMed ID: 22520016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas.
    Streiff MB; Segal J; Grossman SA; Kickler TS; Weir EG
    Cancer; 2004 Apr; 100(8):1717-23. PubMed ID: 15073862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism and survival in patients with high-grade glioma.
    Simanek R; Vormittag R; Hassler M; Roessler K; Schwarz M; Zielinski C; Pabinger I; Marosi C
    Neuro Oncol; 2007 Apr; 9(2):89-95. PubMed ID: 17327573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism.
    Riedl J; Preusser M; Nazari PM; Posch F; Panzer S; Marosi C; Birner P; Thaler J; Brostjan C; Lötsch D; Berger W; Hainfellner JA; Pabinger I; Ay C
    Blood; 2017 Mar; 129(13):1831-1839. PubMed ID: 28073783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of venous thrombosis and tissue factor in epithelial ovarian cancer.
    Cohen JG; Prendergast E; Geddings JE; Walts AE; Agadjanian H; Hisada Y; Karlan BY; Mackman N; Walsh CS
    Gynecol Oncol; 2017 Jul; 146(1):146-152. PubMed ID: 28501328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
    Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C
    Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS).
    Riedl J; Kaider A; Reitter EM; Marosi C; Jäger U; Schwarzinger I; Zielinski C; Pabinger I; Ay C
    Thromb Haemost; 2014 Apr; 111(4):670-8. PubMed ID: 24306221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study.
    Holst AG; Jensen G; Prescott E
    Circulation; 2010 May; 121(17):1896-903. PubMed ID: 20404252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of tissue factor in glioma.
    Hamada K; Kuratsu J; Saitoh Y; Takeshima H; Nishi T; Ushio Y
    Noshuyo Byori; 1996 Nov; 13(2):115-8. PubMed ID: 8958516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism.
    Mir Seyed Nazari P; Riedl J; Preusser M; Posch F; Thaler J; Marosi C; Birner P; Ricken G; Hainfellner JA; Pabinger I; Ay C
    J Thromb Haemost; 2018 Jun; 16(6):1121-1127. PubMed ID: 29676036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS).
    Königsbrügge O; Pabinger I; Ay C
    Thromb Res; 2014 May; 133 Suppl 2():S39-43. PubMed ID: 24862144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism in patients with pancreatic cancer: implications of circulating tissue factor.
    Delluc A; Rousseau A; Delluc C; Le Moigne E; Le Gal G; Mottier D; Van Dreden P; Lacut K
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):295-300. PubMed ID: 21372691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.